Invention Grant
- Patent Title: Method for enhancing the bioavailability of ospemifene
-
Application No.: US14310822Application Date: 2014-06-20
-
Publication No.: US09241915B2Publication Date: 2016-01-26
- Inventor: Markku Anttila
- Applicant: Hormos Medical LTD.
- Applicant Address: US MI Ann Arbor
- Assignee: QuatRx Pharmaceuticals
- Current Assignee: QuatRx Pharmaceuticals
- Current Assignee Address: US MI Ann Arbor
- Agency: Brinks Gilson & Lione
- Agent Ryan L. Marshall
- Main IPC: A61K31/085
- IPC: A61K31/085 ; A61K31/075 ; A23L1/29

Abstract:
This invention relates to a method for enhancing the bioavailability of a therapeutically active compound of the formula (I) or a geometric isomer, a stereoisomer, a pharmaceutically acceptable salt, an ester thereof or a metabolite thereof, wherein said compound is administered orally to the individual in connection with the intake of food.
Public/Granted literature
- US20140303259A1 METHOD FOR ENHANCING THE BIOAVAILABILITY OF OSPEMIFENE Public/Granted day:2014-10-09
Information query